California Institute of Technology

Who: Almirall/Absci What: Absci will use its generative AI technology to discover drug candidates for two dermatological targets for Almirall. Why: Almirall committed this year to bringing in mor

Erasca Five-Year Collaboration With MD Anderson Focused On MAPKlamp Combo Precision oncology-focused Erasca, Inc. inked a research and development collaboration on 23 August with the University of

With COVID-19, coronaviruses have been the focus of recent drug development efforts, but their tendency to mutate has made them a difficult beast to tame. As a precursor to the development of a pan-co

The biopharmaceutical industry set a new record in venture capital financing raised in a single year, with one quarter left to go in 2021. Drug developers raised $28bn in VC funding through the third